Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001263312-26-000003
Filing Date
2026-03-25
Accepted
2026-03-25 18:46:39
Documents
2
Period of Report
2026-03-23

Document Format Files

Seq Description Document Type Size
1 form3-03252026_100333.html 3  
1 form3-03252026_100333.xml 3 4712
2 ex24-03252026_100342.htm EX-24 4042
  Complete submission text file 0001263312-26-000003.txt   10125
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5505 ENDEAVOR LANE MADISON WI 53719
Business Address
ORVILLE JACOB A (Reporting) CIK: 0001263312 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-02189 | Film No.: 26793897